142 related articles for article (PubMed ID: 10520506)
1. [Huperzine a: an acetylcholinesterase inhibitor with high pharmacological potential].
Pilotaz F; Masson P
Ann Pharm Fr; 1999 Sep; 57(5):363-73. PubMed ID: 10520506
[TBL] [Abstract][Full Text] [Related]
2. Role of huperzine a in the treatment of Alzheimer's disease.
Desilets AR; Gickas JJ; Dunican KC
Ann Pharmacother; 2009 Mar; 43(3):514-8. PubMed ID: 19240260
[TBL] [Abstract][Full Text] [Related]
3. Huperzine a as potential treatment of Alzheimer's disease: an assessment on chemistry, pharmacology, and clinical studies.
Ha GT; Wong RK; Zhang Y
Chem Biodivers; 2011 Jul; 8(7):1189-204. PubMed ID: 21766442
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease.
Zhang HY; Tang XC
Trends Pharmacol Sci; 2006 Dec; 27(12):619-25. PubMed ID: 17056129
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease.
Wang R; Tang XC
Neurosignals; 2005; 14(1-2):71-82. PubMed ID: 15956816
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
Camps P; El Achab R; Görbig DM; Morral J; Muñoz-Torrero D; Badia A; Eladi Baños J; Vivas NM; Barril X; Orozco M; Luque FJ
J Med Chem; 1999 Aug; 42(17):3227-42. PubMed ID: 10464010
[TBL] [Abstract][Full Text] [Related]
8. Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine.
Wang R; Yan H; Tang XC
Acta Pharmacol Sin; 2006 Jan; 27(1):1-26. PubMed ID: 16364207
[TBL] [Abstract][Full Text] [Related]
9. Improving effects of huperzine A on spatial working memory in aged monkeys and young adult monkeys with experimental cognitive impairment.
Ye JW; Cai JX; Wang LM; Tang XC
J Pharmacol Exp Ther; 1999 Feb; 288(2):814-9. PubMed ID: 9918593
[TBL] [Abstract][Full Text] [Related]
10. An update on huperzine A as a treatment for Alzheimer's disease.
Little JT; Walsh S; Aisen PS
Expert Opin Investig Drugs; 2008 Feb; 17(2):209-15. PubMed ID: 18230054
[TBL] [Abstract][Full Text] [Related]
11. Huperzine A--an interesting anticholinesterase compound from the Chinese herbal medicine.
Patocka J
Acta Medica (Hradec Kralove); 1998; 41(4):155-7. PubMed ID: 9951045
[TBL] [Abstract][Full Text] [Related]
12. Non-cholinergic effects of huperzine A: beyond inhibition of acetylcholinesterase.
Zhang HY; Yan H; Tang XC
Cell Mol Neurobiol; 2008 Feb; 28(2):173-83. PubMed ID: 17657601
[TBL] [Abstract][Full Text] [Related]
13. Huperzine A (shuangyiping): a promising drug for Alzheimer's disease.
Tang XC
Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):481-4. PubMed ID: 9863136
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vitro and in vivo release studies of Huperzine A loaded microspheres for the treatment of Alzheimer's disease.
Liu WH; Song JL; Liu K; Chu DF; Li YX
J Control Release; 2005 Oct; 107(3):417-27. PubMed ID: 16154224
[TBL] [Abstract][Full Text] [Related]
15. New insights into huperzine A for the treatment of Alzheimer's disease.
Zhang HY
Acta Pharmacol Sin; 2012 Sep; 33(9):1170-5. PubMed ID: 22941287
[TBL] [Abstract][Full Text] [Related]
16. Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease.
Huang XT; Qian ZM; He X; Gong Q; Wu KC; Jiang LR; Lu LN; Zhu ZJ; Zhang HY; Yung WH; Ke Y
Neurobiol Aging; 2014 May; 35(5):1045-54. PubMed ID: 24332448
[TBL] [Abstract][Full Text] [Related]
17. [Studies on analogues of huperzine A for treatment of senile dementia. VI. Asymmetric total synthesis of 14-nor-huperzine A and its inhibitory activity of acetylcholinesterase].
He XC; Yu GL; Bai DL
Yao Xue Xue Bao; 2003 May; 38(5):346-9. PubMed ID: 12958837
[TBL] [Abstract][Full Text] [Related]
18. Identification of amino acid residues involved in the binding of Huperzine A to cholinesterases.
Saxena A; Qian N; Kovach IM; Kozikowski AP; Pang YP; Vellom DC; Radić Z; Quinn D; Taylor P; Doctor BP
Protein Sci; 1994 Oct; 3(10):1770-8. PubMed ID: 7849595
[TBL] [Abstract][Full Text] [Related]
19. Systemic administration of the potential countermeasure huperzine reversibly inhibits central and peripheral acetylcholinesterase activity without adverse cognitive-behavioral effects.
Myers TM; Sun W; Saxena A; Doctor BP; Bonvillain AJ; Clark MG
Pharmacol Biochem Behav; 2010 Jan; 94(3):477-81. PubMed ID: 19909771
[TBL] [Abstract][Full Text] [Related]
20. Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer's Disease.
Friedli MJ; Inestrosa NC
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
